Domov › Steatotické ochorenie pečene › Texas

Klinické štúdie Steatotické ochorenie pečene v štáte Texas

20 štúdií pre Steatotické ochorenie pečene hľadá účastníkov v zariadeniach v štáte Texas.

Mestá v štáte Texas

Oficiálny text štúdie (anglicky)

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

GSK Investigational Site, Arlington
GSK Investigational Site, Austin
GSK Investigational Site, Bellaire
a 5 ďalších

Prebieha náborFáza 3

Vek 18 až 75 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07704892

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

GSK Investigational Site, Arlington
GSK Investigational Site, Austin
GSK Investigational Site, Bellaire
a 4 ďalších

Prebieha náborFáza 3

Vek 18 až 75 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07701993

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

American Research Corporation, Austin
Advanced Medical Trials, Georgetown
American Research Corporation at The Texas Liver Institute, San Antonio

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT07527910

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

American Research Corporation, Austin
Pinnacle Clinical Research - Austin, Austin
Methodist Dallas Medical Center, Dallas
a 5 ďalších

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

IMA Clinical Research Austin, Austin
American Research Corporation, Austin
Pinnacle Clinical Research, Austin
a 26 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Akero Clinical Study Site, Arlington
Akero Clinical Study Site, Austin
Akero Clinical Study Site, Austin
a 28 ďalších

Prebieha náborFáza 3

Vek 18 až 80 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

GSK Investigational Site, Austin
GSK Investigational Site, Austin
GSK Investigational Site, Brownsville
a 12 ďalších

Prebieha náborFáza 3

Vek 18 až 75 · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07221188

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Pinnacle Clinical Research, Austin
Bellaire Clinical Research, Bellaire
South Texas Research Institute (STRI) - Brownsville, Brownsville
a 14 ďalších

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07288138

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

89bio Clinical Study Site, Amarillo
89bio Clinical Study Site, Austin
89bio Clinical Study Site, Austin
a 30 ďalších

Prebieha náborFáza 3

Vek 18 až 80 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06318169

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

89bio Clinical Study Site, Amarillo
89bio Clinical Study Site, Austin
89bio Clinical Study Site, Austin
a 21 ďalších

Prebieha náborFáza 3

Vek 18 až 75 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06419374

Quantifying Hepatic Mitochondrial Fluxes in Humans

Texas Diabetes Institute - University Health System, San Antonio
University of Texas Health Science Center at San Antonio, San Antonio

Prebieha náborFáza 4

Vek 18 až 80 · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT05305287

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

GSK Investigational Site, Arlington
GSK Investigational Site, Austin
GSK Investigational Site, Dallas
a 4 ďalších

Prebieha náborFáza 2

Vek 18 až 70 · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

GSK Investigational Site, Arlington
GSK Investigational Site, Austin
GSK Investigational Site, Austin
a 16 ďalších

Prebieha náborFáza 3

Vek 18 až 75 · Všetky pohlavia · Aktualizované 27. 7. 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

GSK Investigational Site, Austin
GSK Investigational Site, Austin
GSK Investigational Site, Austin
a 10 ďalších

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 8. 7. 2026 · NCT06920043

A Study of Efimosfermin Alfa in Adults With Hepatic Impairment

GSK Investigational Site, San Antonio

Prebieha náborFáza 1

Vek 18 až 70 · Všetky pohlavia · Aktualizované 9. 6. 2026 · NCT07358546

Evaluating the Pharmacokinetics and Safety of Miricorilant

Site# 433, San Antonio

Prebieha náborFáza 1

Vek 18 až 75 · Všetky pohlavia · Aktualizované 26. 5. 2026 · NCT07553663

Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population

Methodist Dallas Medical Center, Dallas

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 5. 2026 · NCT06225193

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Pioneer Research Solutions, Houston

Prebieha náborFáza 1/2Vítaní zdravých dobrovoľníkov

Vek 18 až 75 · Všetky pohlavia · Aktualizované 16. 4. 2026 · NCT05648214

NAFLD Clinical Care Pathway

Michael E. DeBakey VA Medical Center, Houston, TX, Houston

Prebieha náborVítaní zdravých dobrovoľníkov

Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 11. 2025 · NCT06671886

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

First Surgical Hospital, Bellaire
Endeavor Clinical Trials, San Antonio

Prebieha náborObservačná štúdia

Vek 18 až 75 · Všetky pohlavia · Aktualizované 14. 8. 2025 · NCT07122700

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.